Overview

Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blind, Parallel-group Study to Evaluate the Effect of Bydureon Compared with Placebo on 24-hour Glucose Control in Metformin-treated Patients with Type 2 Diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Exenatide
Metformin